Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors
Clinical trial NCT05801133 · UNKNOWN
Trial details
- NCT number
- NCT05801133
- Sponsor
- Hubei Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-31
- Primary completion
- 2025-03-31
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.